A group of 59 South Koreans detained in Cambodia for alleged involvement in online scams have been repatriated in handcuffs.
The group arrived at Incheon Airport on Saturday morning, several days after South Korea sent a team to Cambodia to…
A group of 59 South Koreans detained in Cambodia for alleged involvement in online scams have been repatriated in handcuffs.
The group arrived at Incheon Airport on Saturday morning, several days after South Korea sent a team to Cambodia to…
Roberson is known for her powerful tumbling. Her floor routine this season has included as many as three variations on a double layout backflip. Saturday morning, however, she performed a slightly easier version of the routine she’s shown in…
9.20pm, BBC One
The American authorities are in Mexico demanding answers about Flight CBZ517: was the aircraft even legit? Flashbacks show the moment the survivors discover the big secret behind the crash for…
Mercialys SA recently announced that Deputy CEO Elizabeth Blaise will leave her position at the end of 2025, following more than 10 years with the company, while also reaffirming its upgraded 2025 financial guidance and positive operational performance through September.
The continuation of leadership stability until year-end, alongside confirmed increases in footfall and tenant sales, highlights management’s confidence in Mercialys’ current strategy and outlook.
With the reaffirmed full-year guidance and reported growth in key operating metrics, we’ll examine how these developments impact Mercialys’ investment narrative.
Trump’s oil boom is here – pipelines are primed to profit. Discover the 22 US stocks riding the wave.
To believe in Mercialys as a shareholder, one needs conviction in the resilience of French shopping centers and the company’s ability to drive earnings despite sector headwinds. The recent announcement about Deputy CEO Elizabeth Blaise’s planned departure at year-end 2025 does not materially affect the most important near-term catalyst, continued operational gains and the execution of retenanting strategies; the main risk remains exposure to regional economic shifts and the evolving retail environment.
Among recent company developments, Mercialys’ reaffirmation of its upgraded 2025 financial guidance stands out. With reported increases in both footfall and tenant sales, management has underscored its short-term confidence in the business, even as leadership transitions are on the horizon, highlighting the operational focus behind earnings stability.
By contrast, investors should be aware that persistent regional demographic changes could…
Read the full narrative on Mercialys (it’s free!)
Mercialys’ narrative projects €206.6 million revenue and €134.6 million earnings by 2028. This requires 5.4% yearly revenue growth and a €103.2 million increase in earnings from €31.4 million today.
Uncover how Mercialys’ forecasts yield a €13.20 fair value, a 22% upside to its current price.
Simply Wall St Community members provided two fair value estimates ranging from €13.20 to €15.97 per share. While forecasts vary, the reaffirmed 2025 guidance and continued operational momentum remain key to the evolving performance outlook for Mercialys.
Explore 2 other fair value estimates on Mercialys – why the stock might be worth just €13.20!
Disagree with existing narratives? Create your own in under 3 minutes – extraordinary investment returns rarely come from following the herd.
Redmi has already confirmed that the upcoming K90 line will have a Pro Max member – its next flagship device – and that the series will be officially announced on October 23.
Ahead of that, the brand has also published a quick hands-on…
Suzanne Noonan, a mother of three children, struggled for months with debilitating anxiety, hot flushes and poor sleep but was afraid to look for hormone replacement therapy (HRT) as there is a history of breast cancer in her family.
A friend, a…
KARACHI: Pakistan’s food trade deficit shot up to $1.14 billion in the first…
SINGAPORE, Oct. 18, 2025 /PRNewswire/ — SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing next-generation immunotherapies for infectious diseases…
Chinese officials tried to ease concerns over its shock escalation of rare earth curbs while traveling in Washington, attempting to soften an international backlash while trade negotiations with the US proceed.
Chinese delegates told their global counterparts that tightened export controls will not harm normal trade flows, in discussions on the sidelines of the International Monetary Fund’s annual meetings this week, according to people familiar with the matter.